{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T14:59:40Z","timestamp":1725548380805},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.oftal.2018.06.011","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T21:56:06Z","timestamp":1537912566000},"page":"580-585","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Faco-esclerectom\u00eda profunda no perforante como tratamiento de la hipertensi\u00f3n ocular secundaria al implante intrav\u00edtreo de dexametasona"],"prefix":"10.1016","volume":"93","author":[{"given":"A.","family":"P\u00e9rez-Sarriegui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Casas-Llera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"D\u00edez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moreno-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gonz\u00e1lez-Mart\u00edn-Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Mu\u00f1oz-Negrete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rebolleda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2018.06.011_bib0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/IAE.0b013e318188c814","article-title":"Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema","volume":"29","author":"Haller","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.oftal.2018.06.011_bib0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archophthalmol.2010.21","article-title":"Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema","volume":"128","author":"Haller","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0135","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/IAE.0000000000001364","article-title":"Ocular hypertension after intravitreal dexamethasone (ozurdex) sustained-release implant","volume":"37","author":"Chin","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oftal.2018.06.011_bib0140","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2018.06.011_bib0145","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ajo.2014.09.003","article-title":"Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: Indications, outcomes, and reinjection frequency","volume":"158","author":"Zarranz-Ventura","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0150","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.ophtha.2014.07.002","article-title":"A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema","volume":"121","author":"Gillies","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2018.06.011_bib0155","first-page":"139","article-title":"Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema","volume":"5","author":"Herrero-Vanrell","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.17925\/USOR.2011.04.02.107","article-title":"Review of the drug-infused eye implant: Ozurdex (dexamethasone intravitreal implant)","volume":"4","author":"Lowder","year":"2011","journal-title":"US Ophthal Rev"},{"key":"10.1016\/j.oftal.2018.06.011_bib0165","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ophtha.2014.02.003","article-title":"Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis","volume":"121","author":"Tomkins-Netzer","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2018.06.011_bib0170","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/IAE.0000000000000443","article-title":"Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema","volume":"35","author":"Scaramuzzi","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oftal.2018.06.011_bib0175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.survophthal.2012.08.003","article-title":"Intraocular pressure monitoring post intravitreal steroids: A systematic review","volume":"58","author":"Kiddee","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0180","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5301\/ejo.5000585","article-title":"Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion","volume":"25","author":"Caillaux","year":"2014","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0185","first-page":"163","article-title":"Corticosteroid-induced ocular hypertension and glaucoma: A brief review and update of the literature","volume":"17","author":"Jones","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0190","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/IAE.0000000000001369","article-title":"Safety of intravitreal dexamethasone implant (Ozurdex): The safodex study. Incidence and risk factors of ocular hypertension","volume":"37","author":"Malcl\u00e8s","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oftal.2018.06.011_bib0195","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/IAE.0000000000000524","article-title":"Observed complications from dexamethasone intravitreal implant for the treatment of macular edema in retinal vein occlusion over 3 treatment rounds","volume":"35","author":"Reid","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.oftal.2018.06.011_bib0200","first-page":"1255","article-title":"Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study","volume":"9","author":"Lam","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0205","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00417-009-1255-7","article-title":"Comparison between phaco-deep sclerectomy and phaco-deep sclerectomy reconverted into phaco-trabeculectomy: Series of fellow eyes","volume":"248","author":"Cabarga-Nozal","year":"2010","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0210","first-page":"499","article-title":"Non-penetrating deep sclerectomy combined with phacoemulsification. Results and complications","volume":"78","author":"Mu\u00f1oz Negrete","year":"2003","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/IAE.0b013e318297f842","article-title":"Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study)","volume":"34","author":"Capone","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oftal.2018.06.011_bib0220","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2018.06.011_bib0225","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0230","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2018.06.011_bib0235","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/08820538.2013.874466","article-title":"Combined non-penetrating deep sclerectomy with phacoemulsification versus non-penetrating deep sclerectomy alone","volume":"29","author":"Bilgin","year":"2014","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.oftal.2018.06.011_bib0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3928\/1542-8877-20020301-05","article-title":"Comparison of trabeculectomy with mitomycin C with or without phacoemulsification and lens implantation","volume":"33","author":"Kleinmann","year":"2002","journal-title":"Ophthalmic Surg Lasers"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669118302211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669118302211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T18:53:27Z","timestamp":1662144807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365669118302211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0365669118302211"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2018.06.011","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faco-esclerectom\u00eda profunda no perforante como tratamiento de la hipertensi\u00f3n ocular secundaria al implante intrav\u00edtreo de dexametasona","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2018.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}